BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23323779)

  • 1. Inspired by nature: fundamentals in nanotechnology design to overcome biological barriers.
    Avila-Olias M; Pegoraro C; Battaglia G; Canton I
    Ther Deliv; 2013 Jan; 4(1):27-43. PubMed ID: 23323779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of multifunctional nanoemulsion systems to overcome oral and CNS drug delivery barriers.
    Ganta S; Deshpande D; Korde A; Amiji M
    Mol Membr Biol; 2010 Oct; 27(7):260-73. PubMed ID: 20929336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug targeting by surface cationization.
    Blau S; Jubeh TT; Haupt SM; Rubinstein A
    Crit Rev Ther Drug Carrier Syst; 2000; 17(5):425-65. PubMed ID: 11108156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanobiotechnology-based drug delivery to the central nervous system.
    Jain KK
    Neurodegener Dis; 2007; 4(4):287-91. PubMed ID: 17627131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of polymeric nanoparticles in the targeting drugs carriers].
    Li S; Liu X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):495-7. PubMed ID: 15250165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of nanocarriers for the delivery of small interfering RNA.
    Kesharwani P; Gajbhiye V; Jain NK
    Biomaterials; 2012 Oct; 33(29):7138-50. PubMed ID: 22796160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug delivery systems using nano-sized drug carriers].
    Nakayama M; Okano T
    Gan To Kagaku Ryoho; 2005 Jul; 32(7):935-40. PubMed ID: 16044950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy for effective brain drug delivery.
    Alam MI; Beg S; Samad A; Baboota S; Kohli K; Ali J; Ahuja A; Akbar M
    Eur J Pharm Sci; 2010 Aug; 40(5):385-403. PubMed ID: 20497904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Breaking down barriers--about the art of escorting drugs into the brain].
    Kahl U
    Lakartidningen; 2003 Jan; 100(3):136-7. PubMed ID: 12596480
    [No Abstract]   [Full Text] [Related]  

  • 10. Nanotechnology in ocular drug delivery.
    Sahoo SK; Dilnawaz F; Krishnakumar S
    Drug Discov Today; 2008 Feb; 13(3-4):144-51. PubMed ID: 18275912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systems-level thinking for nanoparticle-mediated therapeutic delivery to neurological diseases.
    Curtis C; Zhang M; Liao R; Wood T; Nance E
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Mar; 9(2):. PubMed ID: 27562224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Medical applications of nanotechnology: polymeric micelles for drug delivery].
    Nishiyama N; Kataoka K
    Nihon Geka Gakkai Zasshi; 2005 Nov; 106(11):700-5. PubMed ID: 16304818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming in vivo barriers to targeted nanodelivery.
    Chrastina A; Massey KA; Schnitzer JE
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(4):421-37. PubMed ID: 21538941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered nanoscaled polyplex gene delivery systems.
    Fernandez CA; Rice KG
    Mol Pharm; 2009; 6(5):1277-89. PubMed ID: 19385668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered nanoparticles as precise drug delivery systems.
    Yih TC; Al-Fandi M
    J Cell Biochem; 2006 Apr; 97(6):1184-90. PubMed ID: 16440317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymeric nanoparticles - targeted drug delivery systems for treatment of CNS disorders and their possible endocrine disrupting activities.
    Rollerova E; Scsukova S; Jurcovicova J; Mlynarcikova A; Szabova E; Kovriznych J; Zeljenkova D
    Endocr Regul; 2011 Jan; 45(1):49-60. PubMed ID: 21314211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotechnological advances for the delivery of CNS therapeutics.
    Wong HL; Wu XY; Bendayan R
    Adv Drug Deliv Rev; 2012 May; 64(7):686-700. PubMed ID: 22100125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Function of nanoparticles in transdermal and transmucosal drug delivery systems].
    Li J; Dong AJ
    Zhongguo Zhong Yao Za Zhi; 2004 Mar; 29(3):193-6. PubMed ID: 15706836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy.
    Parhi P; Mohanty C; Sahoo SK
    Drug Discov Today; 2012 Sep; 17(17-18):1044-52. PubMed ID: 22652342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug targeting. Breaking down barriers.
    Miller G
    Science; 2002 Aug; 297(5584):1116-8. PubMed ID: 12183610
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.